Story
Virbac Shares Gain After First-Half Revenue Beats Analyst Estimates
Summary
French animal health firm Virbac saw its shares rise after posting first-half revenue that surpassed analyst expectations and confirming its full-year financial targets.
Shares in Virbac (EPA:VIRB) gained more than 3% on Tuesday after the French animal health company reported first-half revenue that beat analyst forecasts and confirmed its full-year outlook at the upper end of its guidance range.
The positive market reaction underscores investor confidence in the company's growth trajectory and operational performance heading into the second half of the year.
Strong First-Half Performance
Virbac announced first-half revenue of €768 million ($877 million), marking a 7.4% increase at constant exchange rates, according to its latest financial release.
For the second quarter, the company's sales reached €384 million. This figure narrowly surpassed the LSEG consensus estimate of €381 million, providing a positive surprise for the market.
Growth Drivers and Outlook
AdAccording to an analysis by TP ICAP Midcap, Virbac's growth is increasingly being driven by fundamentals rather than price hikes. The analysts noted that volume and product mix contributed approximately 5.4 percentage points to revenue growth, while pricing accounted for about 2 percentage points.
Virbac stated that the growth was balanced across its companion and farm animal businesses. The company also highlighted contributions from its "Supercharge" strategic platforms and the recent acquisition of Thyronorm.
Looking ahead, Virbac reaffirmed its full-year 2026 financial targets, which include:
- Revenue growth between 5.5% and 7.5%
- A recurring operating margin of approximately 17%
The company specified that it expects to achieve results at the upper end of this guidance.
Read next
More on Stocks
Live Oak Acquisition Corp. VI Raises $230 Million in Nasdaq IPO
The special purpose acquisition company (SPAC) has completed its initial public offering of 23 million units, which began trading on the Nasdaq Global Market under the ticker 'LOVIU'.
Akamai Shares Surge 20% After Securing $11.6 Billion AI Cloud Deal With Anthropic
The cloud services provider announced a seven-year, $11.6 billion contract to support Anthropic's AI infrastructure, sending its stock soaring in after-hours trading.
Akamai Secures $11.6 Billion, Seven-Year Cloud Deal with AI Firm Anthropic
Akamai Technologies announced a landmark $11.6 billion, seven-year agreement to provide cloud computing services to artificial intelligence company Anthropic, securing a major contract in the competitive AI infrastructure market.
Zscaler Shares Fall Over 4% After Naming New Chief Revenue Officer
The cybersecurity company's stock declined in after-hours trading following the announcement that it appointed Ross Tackett to replace Mike Rich as CRO, effective October 1.